New Inpatient Visitor Check-In Process Effective March 10. Learn more here.
Research Leaders
-
Cancer Center Director Jonathan Chernoff, MD, PhD
Senior Vice President
Stanley P. Reimann Chair in Oncology ResearchJonathan Chernoff works with Temple University Health System and Temple University leadership to guide Fox Chase into the future of cancer care. A molecular oncologist and medical oncologist, he helps Fox Chase focus on areas that best leverage the institution’s strengths in scientific development.
-
Deputy Director Elizabeth Plimack, MD, MS
Professor, Department of Hematology/Oncology
Director, Genitourinary Clinical Research -
Chief Scientific Officer David Wiest, PhD
Scientific Director of the Research Institute of Fox Chase Cancer Center
Professor
Associate Directors
-
Clinical Trial Integration Martin J. Edelman, MD
Chair and Professor, Department of Hematology/Oncology
Deputy Cancer Center Director for Clinical Research
G. Morris Dorrance Jr. Chair in Medical OncologyMartin Edelman’s research focuses on interdisciplinary and multimodality treatment of lung cancer with the goal of translating laboratory observations into practical clinical trials. His role at Fox Chase is to facilitate interactions between laboratory and clinical investigators.
-
Population Science Carolyn Y. Fang, PhD
Professor, Cancer Prevention and Control
Carolyn Y. Fang studies how psychosocial and behavioral factors influence cancer risk and outcomes, particularly in underserved populations. Her work has made significant contributions to informing evidence-based approaches for addressing cancer health disparities.
-
System Integration Erica Golemis, PhD
Deputy Chief Science Officer
Professor, Cancer Signaling and Microenvironment
William Wikoff Smith Chair in Cancer ResearchAs Associate Director for System Integration, Erica Golemis works with Fox Chase and Temple scientists to develop relationships that will lead Fox Chase into the future. As chair of the Department of Cancer and Cell Biology at the Lewis Katz School of Medicine, she focuses on identifying and supporting research synergies that advance cancer research and cancer care.
-
Administration & Planning John Gricoski
Vice President, Research Administration
John Gricoski is responsible for administration of the center, including oversight of research operating and capital budgets, and laboratory space planning. He also manages the NCI Cancer Center Support Grant. Gricoski has an MBA in finance and is a licensed Pennsylvania CPA.
-
Associate Director for Diversity, Equity, Inclusion and Accessibility Camille Ragin, PhD, MPH
Professor, Cancer Prevention and Control
Camille Ragin’s research focuses on gene-environment interactions and cancer health disparities. Her work applies molecular biomarkers, genomics, and public health tools to cancer research in African American communities and African-descended populations worldwide.
-
Cancer Research Training and Education Glenn F. Rall, PhD
Chief Academic Officer
Professor, Cancer Signaling and MicroenvironmentRall focuses on the intersection of virology, immunology, and neurobiology. As associate director of education and training, Rall oversees all faculty affairs, as well as mentoring and education programs.
-
Clinical Research Margaret von Mehren, MD
Chief, Division of Sarcoma Medical Oncology
Vice Chair and Professor, Department of Hematology/Oncology
Physician Director Office of Clinical ResearchMargaret von Mehren’s research focuses on developmental therapeutics for sarcomas and gastrointestinal stromal tumors. Her work in this area informs her role as the associate director for clinical research, in which she oversees much of the clinical trials process at Fox Chase.
-
Community Outreach and Engagement (COE) Charnita Zeigler-Johnson, PhD, MPH
Charnita Zeigler-Johnson works with community partners as well as cancer center leadership and clinical chairs to address the needs of the communities that Fox Chase serves. She also integrates community-engaged research across scientific programs at Fox Chase and Temple Health.
Research Program Leaders
-
Cancer Prevention and Control Program Margie L. Clapper, PhD
Co-Leader, Cancer Prevention and Control
Professor
Samuel M.V. Hamilton Chair in Cancer Prevention -
Cancer Prevention and Control Program Michael J. Hall, MD, MS
Chair and Professor, Department of Clinical Genetics
Director, Gastrointestinal Risk Assessment
Co-Leader, Cancer Prevention and Control Program -
Cancer Signaling and Microenvironment Program Edna (Eti) Cukierman, PhD
Co-Leader, Cancer Signaling and Microenvironment
Co-Director, Marvin & Concetta Greenberg Pancreatic Cancer Institute
Co-Director, Immune Monitoring Facility -
Cancer Signaling and Microenvironment Program -
Nuclear Dynamics and Cancer Program Tomasz Skorski, MD, PhD, DSc
Co-Leader and Professor, Nuclear Dynamics and Cancer
Professor, Department of Cancer and Cellular Biology
-
Nuclear Dynamics and Cancer Program Johnathan R. Whetstine, PhD
Co-Leader and Professor, Nuclear Dynamics and Cancer Program
Director, Cancer Epigenetics Institute
Jack Schultz Chair in Basic Science
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this